Registration Dossier

Administrative data

Description of key information

No data are available for the carcinogenicity of D6. However, further testing is not considered necessary at this point because:

• There is no evidence from the existing data for mutagenicity that the substance should be classified for this endpoint.

• There is no evidence from the repeated dose studies that the substance is able to induce hyperplasia or pre-neoplastic lesions.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

There is no evidence to suggest that D6 should be classified for carcinogenicity.